DTIL - Eli Lilly subsidiary Precision Biosciences end gene therapy collaboration
2024-04-16 16:59:57 ET
More on Precision BioSciences
- Precision BioSciences stock falls after pricing $40M securities offering
- Precision BioSciences announces proposed public offering of common stock and warrants
- Seeking Alpha’s Quant Rating on Precision BioSciences
- Historical earnings data for Precision BioSciences
- Financial information for Precision BioSciences